Endocrine and Neuroendocrine Cancers

• Altri autori: Berruti, Alfredo (Redattore), Amoroso, Vito (Redattore), Fazio, Nicola (Redattore)
• Natura: Elettronico Capitolo di libro
• Lingua: inglese
• Pubblicazione: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Soggetti: Medicine; Oncology; neuroendocrine neoplasm; neuroendocrine carcinoma; Ki67 labeling index; Ki67 proliferation index; adrenocortical tissues; EMT; epithelial markers; mesenchymal markers; recurrence-free survival; neuroendocrine neoplasms; molecular targeted therapies; mTOR inhibitors; somatostatin analogs; TPH inhibitors; meta-analysis; medullary thyroid cancer; calcitonin; MEN2; gene carriers; adrenocortical cancer; metastatic pheochromocytoma; metastatic paraganglioma; checkpoint inhibitors; avelumab; ipilimumab; nivolumab; pembrolizumab; neuroendocrine tumor; GEP-NET; PET/CT; PRRT; DOTATOC; crcinoid crisis; neuroendocrine tumors; hemodynamic instability; octreotide; neuroendocrine; molecular profiling; targeted therapies; mutation; fusion; ctDNA; anaplastic thyroid carcinoma; chemotherapy; immune checkpoint inhibitors; tumors associated macrophages; radiotherapy; molecular targeted therapy; gastroenteropancreatic neuroendocrine neoplasms; patient-derived xenograft; tumor spheroids; somatostatin receptor-2; near infrared-labelled octreotide analog; management; Delphi; consensus; pancreatic neuroendocrine tumor; everolimus; angiogenesis; circulating cells; biomarkers; n/a
• Accesso online: DOAB: download the publication; DOAB: description of the publication

Endocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation, disease outcome, and treatments available. This Special Issue addresses specific aspects of pre-clinical, clinical, and translational research and clinical management of these...